Strong organic growth in third quarter driven by the high margin Design & Manufacturing segment. Trading in the third quarter continued strongly and the Group remains on track to deliver its full year performance in line with management’s expectations.
Effective from 1 February 2018, interim CEO & CFO to be retained on a permanent basis while Ian Lawson, the architect of Group strategy since 2013, stands down from the Board of Directors due to ill health which has been well advertised since March 2017.
WANdisco Fusion has been chosen as the standard cloud migration solution for Bytes’ UK customers. Bytes is Microsoft’s largest partner in the UK and has an impressive client roster. The agreement significantly expands WANdisco’s sales channel opportunities.
Positive long-term data from Phase II stroke disability clinical trial. The FDA has given regulatory approval for the Company to commence a Phase IIb clinical study in the US. Data from the study are expected in late 2019.
Kun-Manie Mineral Resource Estimate (“MRE”) expected to be substantially higher than February 2017 estimate after mineralized zone is expanded from 1.4km to 3.6km thanks to newly discovered orebody and independently confirmed drill results.